-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Carlsmed, Raises Price Target to $24

Benzinga·11/07/2025 09:29:23
Listen to the news
BTIG analyst Ryan Zimmerman maintains Carlsmed (NASDAQ:CARL) with a Buy and raises the price target from $21 to $24.